Fensolvi Kit
Product Images NDC 62935-153

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Fensolvi (NDC 62935-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tolmar Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Fensolvi 1)

Figure 1 (Fensolvi 1)
An instructional illustration labeled 'Syringe A Tray Contents' showing Syringe A, a white plunger rod to be used with Syringe B, and the assembled Syringe A. The illustration visually identifies these components as part of the Fensolvi kit by TOLMAR Inc.*
FDA Label Image

Figure 10 (Fensolvi 10)

Figure 10 (Fensolvi 10)
An instructional illustration showing hands wearing blue gloves assembling two syringes labeled Syringe A and Syringe B. The image indicates a twisting motion to connect Syringe A onto Syringe B. This diagram is likely part of the usage instructions for the Fensolvi Leuprolide Acetate kit by TOLMAR Inc.*
FDA Label Image

Step10 (Fensolvi 11)

Step10 (Fensolvi 11)
An instructional image depicting a gloved hand attaching or twisting a needle onto Syringe B, with labels indicating 'Needle' and 'Syringe B' to guide assembly steps in preparing the Fensolvi (Leuprolide Acetate) medication kit.*
FDA Label Image

Figure 12 (Fensolvi 12)

Figure 12 (Fensolvi 12)
Instructional illustration demonstrating preparation of Syringe B in the Fensolvi (Leuprolide Acetate) kit by Tolmar Inc. It shows gloved hands pulling a component from Syringe B, with arrows and numbers indicating the sequence of steps labeled '1' and '2.'*
FDA Label Image

Fig1 (Fensolvi 13)

Fig1 (Fensolvi 13)
An instructional illustration showing a hand pinching the skin on a person's arm, demonstrating a subcutaneous injection technique or skin fold elevation.*
FDA Label Image

Fig2 (Fensolvi 14)

Fig2 (Fensolvi 14)
An instructional illustration showing the proper technique to insert a syringe needle at a 90-degree angle into the skin, demonstrating injection technique likely related to the use of Fensolvi (Leuprolide Acetate) KIT by Tolmar Inc.*
FDA Label Image

Figure 2-4-3 (Fensolvi 15)

Figure 2-4-3 (Fensolvi 15)
An instructional illustration showing a gloved hand holding a syringe with a protective cap. The image includes an arrow indicating the cap should be pushed back, demonstrating how to prepare the syringe for use.*
FDA Label Image

Figure 7 (Fensolvi 16)

Figure 7 (Fensolvi 16)
An instructional illustration showing a gloved hand holding a syringe. The image indicates the action to push a cap or safety cover upward to remove it from the needle, with a directional arrow and the word "Push".*
FDA Label Image

Figure 2-4-5 (Fensolvi 17)

Figure 2-4-5 (Fensolvi 17)
An instructional image showing a gloved hand holding a syringe and needle assembly, with the text 'Click' indicating a step in the preparation or activation process of the Fensolvi kit containing Leuprolide Acetate.*
FDA Label Image

Figure 2-4-6 (Fensolvi 18)

Figure 2-4-6 (Fensolvi 18)
An instructional image showing a hand wearing a blue glove holding a syringe device with a needle protector, demonstrating a step identified by the word "Click" indicating activation or preparation of the device for use.*
FDA Label Image

Formula (Fensolvi 19)

Formula (Fensolvi 19)
Chemical structure of Leuprolide Acetate, the active ingredient in Fensolvi by TOLMAR Inc. The image depicts the molecular structure of this synthetic peptide drug.*
FDA Label Image

Figure 2 (Fensolvi 2)

Figure 2 (Fensolvi 2)
An instructional illustration showing the contents of the Syringe B tray from the Fensolvi kit by TOLMAR Inc. It includes a labeled Syringe B, which is a pre-filled syringe with blue and black components, and a separate needle, labeled accordingly.*
FDA Label Image

Carton (Fensolvi 20)

Carton (Fensolvi 20)
Fensolvi 45 mg kit for injectable suspension containing leuprolide acetate by TOLMAR Inc. Label indicates dosing every 6 months. Packaging includes product name, dosage strength, administration route as subcutaneous injection, storage instructions to refrigerate at 2 to 8°C, and notes that the drug must be reconstituted before use. It is a prescription drug kit with details about syringe contents and delivery system.*
FDA Label Image

Figure 3 (Fensolvi 3)

Figure 3 (Fensolvi 3)
Instructional illustration showing a gloved hand holding Syringe B labeled on the device, while another gloved hand pulls a purple component off from the syringe. The image appears to demonstrate a preparatory step for using the syringe, likely part of the Fensolvi (Leuprolide Acetate) KIT.*
FDA Label Image

Figure 4 (Fensolvi 4)

Figure 4 (Fensolvi 4)
An instructional diagram showing a syringe labeled as Syringe B with a screw component. The image depicts hands wearing blue gloves holding the syringe and screw, illustrating a step in the preparation or assembly process of the product kit, Fensolvi (Leuprolide Acetate) by TOLMAR Inc.*
FDA Label Image

Figure 5 (Fensolvi 5)

Figure 5 (Fensolvi 5)
An instructional illustration showing a gloved hand unscrewing the cap of Syringe A, part of the Fensolvi (Leuprolide Acetate) kit. The image demonstrates the step to unscrew the syringe cap as part of the medication preparation process.*
FDA Label Image

Figure 6 (Fensolvi 6)

Figure 6 (Fensolvi 6)
An instructional illustration showing a gloved hand pulling the cap off Syringe B from the Fensolvi kit containing Leuprolide Acetate. The image highlights the step labeled 'Pull' associated with handling Syringe B during preparation or administration.*
FDA Label Image

Figure 7 (Fensolvi 7)

Figure 7 (Fensolvi 7)
An instructional diagram showing two syringes labeled Syringe A and Syringe B being connected by screwing Syringe A onto Syringe B. Blue-gloved hands hold the syringes during the assembly process. The image illustrates the preparation step for Fensolvi Leuprolide Acetate Kit by TOLMAR Inc.*
FDA Label Image

Figure 8 (Fensolvi 8)

Figure 8 (Fensolvi 8)
Illustration showing two syringes labeled Syringe A and Syringe B held by gloved hands. An arrow between the syringes with text instructs to "Mix for 45 seconds," indicating a preparation step involving the syringes.*
FDA Label Image

Figure 9 (Fensolvi 9)

Figure 9 (Fensolvi 9)
An instructional illustration showing the assembly or connection of two syringes labeled Syringe A and Syringe B, with an arrow indicating Syringe A is being pushed or connected towards Syringe B. Blue-gloved hands hold each syringe, demonstrating proper handling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.